There are provided by the present invention certain pyrazole based CCK-1 receptor modulators.


< Aryl fused 2,4-disubstituted pyridines: NK3 receptor ligands

< Substituted oxazoles and thiazoles as hPPAR alpha agonists

> Preparation and use of aryl alkyl acid derivatives for the treatment of obesity

> Heteroaryloxy 3-substituted propanamines as serotonin and norepinephrine reuptake inhibitors

~ 00258